← Dashboard
Stock
CURX
Curanex Pharmaceuticals IncLatest close $0.302 of 27 marquee funds currently hold1 CUSIP mapped
Current holders
2
27 funds tracked
Ever held
4
Current + past
New this quarter
0
Exited this quarter
1
Marquee-fund ownership over time
Nov 14, 2025Feb 12, 2026Feb 17, 2026May 14, 2026
Now
2
This quarter's activity
New positions opened
None.
Positions exited
Current holders
Sorted by tenure (longest first)| Fund | First disclosed | Held | Entry price | Latest close | Return on entry |
|---|---|---|---|---|---|
| Citadel Advisors | Q4 2025(8Q snapshot) | 2Q | $0.51 | $0.30 | -41% |
| Two Sigma Investments | Q1 2026(8Q snapshot) | 1Q | $0.28 | $0.30 | +7% |
“Return on entry” is the price-only move from the fund's first disclosure to today — it ignores any adds, trims, or dividends. A fund that built its position over multiple quarters has a true cost basis somewhere between entry price and latest close; this figure is the upper bound.
Past holders
Funds that exited at some point| Fund | Last entry | Exited | Entry → Exit | Return |
|---|---|---|---|---|
| Renaissance Technologies | Q1 2026 | Q2 2026 | → $0.31 | +13% |
| Millennium Management | Q4 2025 | Q1 2026 | → $0.28 | -44% |
Fundamentals
XBRL · Curanex Pharmaceuticals IncAnnual figures sourced directly from Curanex Pharmaceuticals Inc's 10-K / 10-Q filings via SEC EDGAR XBRL. Latest fiscal year and the year-over-year change, with up to ten years of history.
Net income
-$4.23M
FY2025-500%+ YoY
EPS (diluted)
$-0.1700
FY2025-467% YoY
Free cash flow(?)
-$10.48M
FY2025-500%+ YoY
Recent SEC filings
10-K · 10-Q · 8-K · 13D/G · proxyThe most recent material filings for Curanex Pharmaceuticals Inc — earnings, material events, ownership disclosures, proxy statements. Form 4 insider activity is shown in the panel above.
- 8-KMaterial eventMay 14, 2026
- 10-QQuarterly reportMay 14, 2026
- 8-KMaterial eventMay 7, 2026
- 8-KMaterial eventApr 2, 2026
- 10-KAnnual reportMar 30, 2026
- 8-KMaterial eventMar 6, 2026
- 8-KMaterial eventJan 5, 2026
- 10-QQuarterly reportNov 17, 2025
- 8-KMaterial eventNov 6, 2025
- 8-KMaterial eventSep 29, 2025
- 8-KMaterial eventSep 12, 2025
- 10-QQuarterly reportSep 9, 2025
- 8-KMaterial eventAug 27, 2025
- 8-KMaterial eventAug 26, 2025
- S-1/ARegistration (IPO, amended)Jul 18, 2025
Trade history
Every open→close lifecycle across tracked funds| Fund | Open date | Close date | Open price | Close price / current | Return |
|---|---|---|---|---|---|
| Two Sigma Investments | Q1 2026 | open | $0.28 | $0.30 | +7% |
| Renaissance Technologies | Q1 2026 | Q2 2026 | $0.28 | $0.31 | +13% |
| Citadel Advisors | Q4 2025 | open | $0.51 | $0.30 | -41% |
| Millennium Management | Q4 2025 | Q1 2026 | $0.51 | $0.28 | -44% |
Caveats
- Covers only the 27 marquee funds tracked here, not the full institutional universe. A “0 holders” reading does not mean unowned.
- Heavy funds (Renaissance Technologies, Citadel Advisors, Soros Fund Management, Two Sigma Investments, D.E. Shaw, AQR Capital Management, Millennium Management, Point72 Asset Management) use 8-quarter snapshots, so their pre-2024 history is missing.
- “Current” reflects each fund's most recent 13F — filings lag the actual trade by up to 45 days; positions shown may have changed since.
- Cost = price at the entry filing date. Re-entered positions show the most recent open lot.
- Options, ADRs, and unmapped CUSIPs are excluded from the follower-backtest pipeline that produces these snapshots, so certain holding types won't appear here.